An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression

Molecules and Cells

Volumn 34, Issue 4, 2012, Pages 357-365

  Jeong, Seung Hun ^a   Song, In Sung ^a   Kim, Hyoung Kyu ^a   Lee, Sung Ryul ^a   Song, Suhee ^b   Suh, Hongsuk ^b   Yoon, Young Geol ^c   Yoo, Young Hyun ^d   Kim, Nari ^a   Rhee, Byoung Doo ^a   Ko, Kyung Soo ^a   Han, Jin ^a  

^a Inje University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Jungwon University   (South Korea)

^d Dong A University   (South Korea)

Author keywords

HS 1793; Mitochondrial biological function; Oxygen consumption rate; Resveratrol; TFAM

Indexed keywords

ELONGATION FACTOR TU; HS 1793; MITOCHONDRIAL TRANSCRIPTION FACTOR A; RESVERATROL; SINGLE STRANDED DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOCHONDRION;

ANTINEOPLASTIC AGENTS; CASPASES; CELL SURVIVAL; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL TURNOVER; NAPHTHOLS; OXIDATIVE PHOSPHORYLATION; RESORCINOLS; STILBENES;

VITACEAE;

EID: 84870383934     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0081-7     Document Type: Article

References (51)

1. Alirol, E., and Martinou, J.C. (2006). Mitochondria and cancer: Is there a morphological connection? Oncogene 25, 4706-4716.
2. Bae, Y.S., Oh, H., Rhee, S.G., and Yoo, Y.D. (2011). Regulation of reactive oxygen species generation in cell signaling. Mol. Cells 32, 491-509.
3. Baines, C.P., Kaiser, R.A., Sheiko, T., Craigen, W.J., and Molkentin, J.D. (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9, 550-555.
4. Bellance, N., Lestienne, P., and Rossignol, R. (2009). Mitochondria: From bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci. 14, 4015-4034.
5. Bhat, K.P., Lantvit, D., Christov, K., Mehta, R.G., Moon, R.C., and Pezzuto, J.M. (2001). Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61, 7456-7463.
6. Bouchier-Hayes, L., Munoz-Pinedo, C., Connell, S., and Green, D.R. (2008). Measuring apoptosis at the single cell level. Methods 44, 222-228.
7. Bove, K., Lincoln, D.W., and Tsan, M.F. (2002). Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 291, 1001-1005.
8. Brownson, D.M., Azios, N.G., Fuqua, B.K., Dharmawardhane, S.F., and Mabry, T.J. (2002). Flavonoid effects relevant to cancer. J. Nutr. 132, 3482S-3489S. Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G.V., and Comi, P. (2007). Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem. Pharmacol. 74, 1568-1574.
9. Clay Montier, L.L., Deng, J.J., and Bai, Y. (2009). Number matters: Control of mammalian mitochondrial DNA copy number. J. Genet. Genomics 36, 125-131.
10. Clement, M.V., Hirpara, J.L., Chawdhury, S.H., and Pervaiz, S. (1998). Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
11. Damianaki, A., Bakogeorgou, E., Kampa, M., Notas, G., Hatzoglou, A., Panagiotou, S., Gemetzi, C., Kouroumalis, E., Martin, P.M., and Castanas, E. (2000). Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell Biochem. 78, 429-441.
12. Dey, R., and Moraes, C.T. (2000). Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J. Biol. Chem. 275, 7087-7094.
13. Ekstrand, M.I., Falkenberg, M., Rantanen, A., Park, C.B., Gaspari, M., Hultenby, K., Rustin, P., Gustafsson, C.M., and Larsson, N.G. (2004). Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 13, 935-944.
14. Ekstrand, M.I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F.S., Trifunovic, A., et al. (2007). Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. USA 104, 1325-1330.
15. Falkenberg, M., Gaspari, M., Rantanen, A., Trifunovic, A., Larsson, N.G., and Gustafsson, C.M. (2002). Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat. Genet. 31, 289-294.
16. Ferry, S., Matsuda, M., Yoshida, H., and Hirata, M. (2002). Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaBmediated cell survival pathway. Carcinogenesis 23, 2031-2041.
17. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O. (1998). Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421, 277-279.
18. Fremont, L. (2000). Biological effects of resveratrol. Life Sci. 66, 663-673.
19. Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2008). Mitochondria in cancer cells: What is so special about them? Trends Cell Biol. 18, 165-173.
20. Gusman, J., Malonne, H., and Atassi, G. (2001). A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22, 1111-1117.
21. Ho, D.J., Calingasan, N.Y., Wille, E., Dumont, M., and Beal, M.F. (2010). Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Exp. Neurol. 225, 74-84.
22. Hsieh, T.C., Burfeind, P., Laud, K., Backer, J.M., Traganos, F., Darzynkiewicz, Z., and Wu, J.M. (1999). Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15, 245-252.
23. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
24. Jeong, S.H., Jo, W.S., Song, S., Suh, H., Seol, S.Y., Leem, S.H., Kwon, T.K., and Yoo, Y.H. (2009a). A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Biochem. Pharmacol. 77, 1337-1347.
25. Jeong, S.H., Lee, J.S., Jeong, N.Y., Kim, T.H., Yoo, K.S., Song, S., Suh, H., Kwon, T.K., Park, B.S., and Yoo, Y.H. (2009b). A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells. Int. J. Oncol. 35, 1353-1360.
26. Joe, A.K., Liu, H., Suzui, M., Vural, M.E., Xiao, D., and Weinstein, I.B. (2002). Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903.
27. Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E.A., Caldwell, S.D., Napper, A., Curtis, R., DiStefano, P.S., Fields, S., et al. (2005). Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-17045.
28. Kang, D., Kim, S.H., and Hamasaki, N. (2007). Mitochondrial transcription factor A (TFAM): Roles in maintenance of mtDNA and cellular functions. Mitochondrion 7, 39-44.
29. Kim, Y.A., Choi, B.T., Lee, Y.T., Park, D.I., Rhee, S.H., Park, K.Y., and Choi, Y.H. (2004). Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol. Rep. 11, 441-446.
30. Kroemer, G., and Pouyssegur, J. (2008). Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13, 472-482.
31. Larsson, N.G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G.S., and Clayton, D.A. (1998). Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 18, 231-236.
32. Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
33. Mahyar-Roemer, M., Kohler, H., and Roemer, K. (2002). Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2, 27.
34. Motta, M.C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., and Guarente, L. (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563.
35. Muth, V., Nadaud, S., Grummt, I., and Voit, R. (2001). Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J. 20, 1353-1362.
36. Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., and Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658.
37. Narayanan, B.A., Narayanan, N.K., Re, G.G., and Nixon, D.W. (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int. J. Cancer 104, 204-212.
38. Qian, W., and Van Houten, B. (2010). Alterations in bioenergetics due to changes in mitochondrial DNA copy number. Methods 51, 452-457.
39. Reddy, M.A., Jain, N., Yada, D., Kishore, C., Vangala, J.R., R.P.S., Addlagatta, A., Kalivendi, S.V., and Sreedhar, B. (2011). Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents. J. Med. Chem. 54, 6751-6760.
40. Savagner, F., Mirebeau, D., Jacques, C., Guyetant, S., Morgan, C., Franc, B., Reynier, P., and Malthiery, Y. (2003). PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. Biochem. Biophys. Res. Commun. 310, 779-784.
41. Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F. (2000). Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85-91.
42. Shadel, G.S., and Clayton, D.A. (1997). Mitochondrial DNA maintenance in vertebrates. Annu. Rev. Biochem. 66, 409-435.
43. Sun, N.J., Woo, S.H., Cassady, J.M., and Snapka, R.M. (1998). DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61, 362-366.
44. Szekeres, T., Saiko, P., Fritzer-Szekeres, M., Djavan, B., and Jager, W. (2011). Chemopreventive effects of resveratrol and resveratrol derivatives. Ann. N Y Acad. Sci. 1215, 89-95.
45. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L., and Weinberg, R.A. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159.
46. Ventura-Clapier, R., Garnier, A., and Veksler, V. (2004). Energy metabolism in heart failure. J. Physiol. 555, 1-13.
47. Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G.M., Budinger, G.R., and Chandel, N.S. (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. USA 107, 8788-8793.
48. Wolter, F., Akoglu, B., Clausnitzer, A., and Stein, J. (2001). Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131, 2197-2203.
49. Yan, Y., Yang, J., Chen, G., Mou, Y., Zhao, Y., Pan, L., Ma, C., Liu, X., and Wu, C. (2011). Protection of resveratrol and its analogues against ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Mutat. Res. 721, 171-177.
50. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., and Mayo, M.W. (2004). Modulation of NF-kappaBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380.
51. Zhang, L., Bao, Y., and Li, J. (2011). Nuclear respiratory factor-1 is involved in mitochondrial dysfunction induced by benzo(a) pyrene in human bronchial epithelial cells. Basic Clin. Pharmacol. Toxicol. 109, 115-122.